Dataset opportunity
Virtuososurgical — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Virtuososurgical, usable for Diagnostic AI and Computer Vision.
Score
70
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in diagnostics market size was valued at USD 7.03 billion in 2025, projected to grow at a CAGR of 41.27%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-11-10
Virtuoso robot wins FDA nod for bladder tumor removal
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- 📣Press / announcement
Development of breakthrough concentric tube robotic technology
source ↗
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Virtuososurgical holds a unique Medical Imaging Dataset composed of a rich `image_collection` of surgical videos, supplemented with `iot_data` from surgical tools and associated `medical_records`. This multi-modal collection provides a comprehensive view of surgical procedures, making it exceptionally valuable for training and validating high-performance Diagnostic AI models designed to analyze complex, real-world operative scenarios and predict patient outcomes.
The global AI in diagnostics market is experiencing explosive growth, valued at $7.03 billion in 2025 and projected to expand at a CAGR of 41.27%. This massive demand makes rare, high-quality surgical video data a critical asset for AI developers. Despite access complexities due to strict HIPAA/FDA regulations and shared clinical data ownership, the dataset's unparalleled depth is essential for creating next-generation AI tools, justifying the negotiation effort for access. ⚠ Diligence (valuable data, access to negotiate): Subject to strict medical data regulations (HIPAA/FDA); Data involves sensitive surgical video and patient outcomes; Ownership of clinical data may be shared with trial hospitals · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence indicates Virtuososurgical possesses a unique, proprietary dataset combining high-definition surgical video with synchronous robotic sensor data and detailed procedural logs. This multimodal collection is a critical asset for medical AI companies developing next-generation diagnostic AI and surgical analytics platforms. In a global AI diagnostics market projected to grow at over 40% annually, this type of rich, contextualized data is essential for achieving clinical-grade accuracy and a competitive edge.
See dimension details ↓- Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
AI buyer demand is exceptionally high, driven by the market's rapid expansion and a projected 41.27% CAGR, creating an urgent need for specialized surgical data to train advanced diagnostic models.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=company_owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — This pre-commercial medical device company is an ideal target, as its core business is developing a physical robotic surgery system, which inherently generates valuable, un-monetized data (surgical video, telemetry) as a by-product. Issues: The company is pre-revenue as of the latest financial filings, with its first product launch planned for 2027.; The company's focus is currently on gaining FDA authorization and commercializing its hardware, so data monetization may not be an immediate priority for them.
- Deep Qualification80
✓ pass — Virtuoso Surgical is a medical device manufacturer, not a data seller. It possesses a unique and valuable dataset from the clinical trials that secured its recent FDA approval. However, the company's business model is selling the device, and the ownership and right to reuse this sensitive clinical data are complex and heavily regulated by HIPAA, making direct acquisition for unrelated AI training highly challenging.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
This evidence points to a collection of robotic sensor data, including movement and force-feedback logs, which is invaluable for training AI in surgical robotics and haptic systems.
Image collection
The company holds high-definition endoscopic video from specialized urological, gynecological, and thoracic procedures, a core asset for training computer vision models for diagnostic AI.
Medical records / imaging
This data consists of detailed procedural metadata, logging surgical steps and tool interactions, which provides the essential ground-truth labeling for developing context-aware surgical analytics.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Virtuososurgical Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in diagnostics market size was valued at USD 7.03 billion in 2025, projected to grow at a CAGR of 41.27% (source: Fortune Business Insights). Investment score 70.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Maslanka — Regulatory Records Dataset Opportunity
View opportunity →healthcareOriginltd — Regulatory Records Dataset Opportunity
View opportunity →healthcareVitestro — Medical Imaging Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- How a Data Transaction Works3 min read
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read